Phase I/II trial explores Gadeta's gamma delta TCR cell therapy GDT-002 for multiple myeloma July 6, 2021 No Comments
BCMA CAR-T cells engineered with membrane-bound IL-15 show increased in vivo activity July 6, 2021 No Comments
Mersana starts phase I/II umbrella study of XMT-1536 in high-grade serous ovarian cancer July 6, 2021 No Comments
Neoantigen-specific cytotoxic T cells show in vivo efficacy in Ewing sarcoma July 2, 2021 No Comments
Phase Ib data for NIS-793 plus spartalizumab in patients with advanced solid tumors July 1, 2021 No Comments
Updated phase I/II data for galinpepimut-S plus Keytruda in WT1-positive ovarian cancer July 1, 2021 No Comments
RSS